IN2014DN03373A - - Google Patents

Download PDF

Info

Publication number
IN2014DN03373A
IN2014DN03373A IN3373DEN2014A IN2014DN03373A IN 2014DN03373 A IN2014DN03373 A IN 2014DN03373A IN 3373DEN2014 A IN3373DEN2014 A IN 3373DEN2014A IN 2014DN03373 A IN2014DN03373 A IN 2014DN03373A
Authority
IN
India
Prior art keywords
compositions
water soluble
sulphate
salt
sodium
Prior art date
Application number
Inventor
Thomas Julius Borody
Sanjay Ramrakha
John Saxon
Antony Wettstein
Original Assignee
Borody Thomas J
Sanjay Ramrakha
John Saxon
Antony Wettstein
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Borody Thomas J, Sanjay Ramrakha, John Saxon, Antony Wettstein filed Critical Borody Thomas J
Publication of IN2014DN03373A publication Critical patent/IN2014DN03373A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Detergent Compositions (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The invention provides compositions for use in purgatives for use as purgatives and to methods for inducing purgation of the colon. In alternative embodiments the invention provides compositions e.g. a purgative comprising: a water soluble sodium salt (especially sodium sulphate) a water soluble potassium salt (especially potassium sulphate) and a water soluble magnesium salt (especially magnesium sulphate); and compositions further comprising: a bisoxatin or a detergent stool softening agent (such as sodium picosulphate) and/or a water soluble sugar (such as xylose or equivalent); or compositions having these ingredients at different amounts but at equivalent proportions. In alternative embodiments the invention provides purgative compositions comprising electrolytes salts sugars bisoxatin dyes and biofilm disruptors.
IN3373DEN2014 2011-10-27 2012-10-27 IN2014DN03373A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161552431P 2011-10-27 2011-10-27
US201261717599P 2012-10-23 2012-10-23
PCT/AU2012/001315 WO2013059881A1 (en) 2011-10-27 2012-10-27 Electrolyte purgatives

Publications (1)

Publication Number Publication Date
IN2014DN03373A true IN2014DN03373A (en) 2015-06-05

Family

ID=48166953

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3373DEN2014 IN2014DN03373A (en) 2011-10-27 2012-10-27

Country Status (14)

Country Link
US (1) US20150056140A1 (en)
EP (1) EP2782581A4 (en)
JP (2) JP6240610B2 (en)
KR (1) KR20140090217A (en)
CN (1) CN104010642B (en)
AU (2) AU2012327212B2 (en)
BR (1) BR112014009946A2 (en)
CA (1) CA2853520C (en)
IL (1) IL232218B (en)
IN (1) IN2014DN03373A (en)
MX (1) MX352891B (en)
PH (1) PH12014500927B1 (en)
RU (1) RU2640920C2 (en)
WO (1) WO2013059881A1 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2821196C (en) 2010-12-13 2022-11-22 Thomas Julius Borody Gastric and colonic formulations and methods for making and using them
TWI535461B (en) 2011-03-11 2016-06-01 諾金私人有限公司 Colon cleansing solution, composition for preparing the solution, kit comprising the composition or solution, and method of preparing the same
PT2877163T (en) 2012-07-27 2019-05-24 Redhill Biopharma Ltd Formulations and methods of manufacturing formulations for use in colonic evacuation
KR20170098980A (en) 2012-09-11 2017-08-30 노어긴 비.브이. Compositions comprising peg and ascorbate
EP3563838A1 (en) 2013-03-15 2019-11-06 Braintree Laboratories, Inc. Dual use oral pharmaceutical composition tablets of suflate salts and methods of use thereof
CN103585173B (en) * 2013-10-28 2016-06-29 王显著 Sulfur acid sodium and can the pharmaceutical composition of sulphuric acid
EP3191105A4 (en) * 2014-09-12 2018-05-02 Braintree Laboratories, Inc. Sulfate salt solution laxative compositions and methods of use thereof
FR3049464B1 (en) * 2016-03-29 2021-08-06 Marc Girard COLIC PREPARATIONS
US10143656B1 (en) 2017-08-04 2018-12-04 Braintree Laboratories, Inc. Solid oral sulfate salt formulations for cleaning a colon and methods of using same
KR102127003B1 (en) * 2017-10-12 2020-06-25 주식회사 한국팜비오 Colonic purgative composition comprising sulfate salts
CN108244627A (en) * 2018-01-16 2018-07-06 广西天昌投资有限公司 A kind of banana oral liquid with ease constipation and preparation method thereof
KR102111094B1 (en) * 2018-06-18 2020-05-14 주식회사 한국팜비오 Oral solid formulation composition for purgative comprising sodium sulfate anhydrous, potassium sulfate, magnesium sulfate anhydrous and simethicone
WO2020006389A1 (en) * 2018-06-29 2020-01-02 Viktor Veniaminovich Tets Compositions for modulating gut microbiota
RU2699222C1 (en) * 2019-04-29 2019-09-04 Алексей Владимирович Воронов Electrolyte salt solution for enteral infusion
RU2709495C1 (en) * 2019-08-01 2019-12-18 Общество с ограниченной ответственностью "Гелеспон" Method for intestine cleaning and kit for its implementation
WO2021133017A1 (en) * 2019-12-23 2021-07-01 주식회사 비보존 Colonic purgative composition
KR20220033810A (en) * 2020-09-10 2022-03-17 강윤식 Bowel Cleansing Supplementary beverage
WO2024256873A1 (en) 2023-06-15 2024-12-19 Sebela Ireland Limited Methods of administering safe colon cleansing compositions
KR20250176963A (en) * 2024-06-13 2025-12-22 주식회사태준제약 Solid formulation for cleansing a colon

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6162464A (en) * 1997-03-31 2000-12-19 Inkine Pharmaceutical, Inc. Non-aqueous colonic purgative formulations
JP2000060487A (en) * 1998-08-27 2000-02-29 Kao Corp Constipation improver
EE04580B1 (en) * 2001-06-29 2006-02-15 Tartu �likool Microorganism strain Lactobacillus fermentum ME-3 as an antimicrobial and antioxidant probiotic
US7101573B2 (en) * 2001-09-28 2006-09-05 Mcneil-Pcc, Inc. Simethicone solid oral dosage form
AUPS088702A0 (en) * 2002-03-04 2002-03-28 Borody, Thomas Julius Electrolyte purgative
JP4458761B2 (en) * 2003-03-27 2010-04-28 ロート製薬株式会社 Axillary preparation
US7687075B2 (en) * 2003-11-19 2010-03-30 Salix Pharmaceuticals, Ltd. Colonic purgative composition with soluble binding agent
GB0409104D0 (en) * 2004-04-23 2004-05-26 Norgine Europe Bv Compressed pharmaceutical compositions
US9125833B2 (en) * 2005-11-02 2015-09-08 Relmada Therapeutics, Inc. Multimodal abuse resistant and extended release opioid formulations
WO2007057924A1 (en) * 2005-11-21 2007-05-24 Panacea Biotec Ltd Laxative composition on the basis of triphala
WO2008021394A2 (en) * 2006-08-15 2008-02-21 Theraquest Biosciences, Llc Pharmaceutical formulations of cannabinoids and method of use
JP2008115085A (en) * 2006-11-01 2008-05-22 Tendou Seiyaku Kk Laxative
US20090155363A1 (en) * 2007-12-14 2009-06-18 Todd Maibach Methods for oral administration of active drugs
US20090258090A1 (en) * 2008-04-11 2009-10-15 Braintree Laboratories, Inc. Colon cleansing solution
WO2011047178A1 (en) * 2009-10-14 2011-04-21 Gi Innovation, Pllc Colon cleansing of residual stool and secretions during colonoscopy
JP2011135936A (en) * 2009-12-25 2011-07-14 Toshiba Corp Image processor, medical image diagnostic apparatus, and image processing program
CA2821196C (en) * 2010-12-13 2022-11-22 Thomas Julius Borody Gastric and colonic formulations and methods for making and using them
BR112013019360A2 (en) * 2011-01-28 2017-03-28 A Shaver William ingredients, dry component of pharmaceutically acceptable low chloride oral colon cleansing formulation, aqueous electrolyte replacement base solution for use in colonic lavage, methods for cleaning the intestines of the patient, for preparing aqueous colon cleansing solution and to substantially increase the taste of colon cleansers and colon evacuation kits.

Also Published As

Publication number Publication date
EP2782581A4 (en) 2015-05-20
JP2018008997A (en) 2018-01-18
NZ723576A (en) 2018-07-27
WO2013059881A1 (en) 2013-05-02
KR20140090217A (en) 2014-07-16
BR112014009946A2 (en) 2017-04-25
CA2853520A1 (en) 2013-05-02
AU2016213892A1 (en) 2016-09-01
IL232218B (en) 2018-10-31
IL232218A0 (en) 2014-06-30
AU2012327212A1 (en) 2013-05-23
EP2782581A1 (en) 2014-10-01
AU2012327212B2 (en) 2016-05-12
PH12014500927A1 (en) 2014-06-16
JP2015510491A (en) 2015-04-09
MX352891B (en) 2017-12-13
CA2853520C (en) 2021-11-16
AU2016213892B2 (en) 2018-04-05
CN104010642A (en) 2014-08-27
RU2640920C2 (en) 2018-01-12
MX2014004962A (en) 2015-01-16
CN104010642B (en) 2018-08-17
NZ624088A (en) 2016-09-30
PH12014500927B1 (en) 2017-09-06
US20150056140A1 (en) 2015-02-26
RU2014121255A (en) 2015-12-10
JP6240610B2 (en) 2017-11-29

Similar Documents

Publication Publication Date Title
IN2014DN03373A (en)
CN102660749B (en) Phosphate-free degreasing agent
AR087845A1 (en) STABLE SOLUBLE ITEMS IN UNITARY DOSE WATER
IN2012DN00306A (en)
NZ743984A (en) Compositions comprising polyethylene glycol, alkali metal or alkaline earth metal sulphates and electrolytes for use as colon cleansing compositions
BR112012017062A2 (en) "Detergent compositions containing geobacillus stearothermophilus lipase and methods for their use"
MX393973B (en) PROTEIN-ACTIVE AGENT CONJUGATES AND METHOD FOR THEIR PREPARATION.
MX336810B (en) Fused benzoxazepinones as ion channel modulators.
MX2014003279A (en) Detergent compositions comprising specific blend ratios of isoprenoid-based surfactants.
WO2011110347A3 (en) Compositions for colon lavage and methods of making and using same
NZ595785A (en) Improvements in and relating to colon cleansing compositions
WO2013043855A3 (en) High suds detergent compositions comprising isoprenoid-based surfactants
GB2486127A (en) Improved deicer composition
MX2011008153A (en) Liquid hand dishwashing detergent composition.
AR064483A1 (en) COMPOSITION FOR WASHING DISHWASHER
RU2013131274A (en) LIQUID CLEANING COMPOSITIONS CONTAINING LONG CHAIN FAT ALCOHOLS
WO2012013742A3 (en) Stabilization of fsh
WO2011007174A3 (en) Composition and method
RU2013156999A (en) COMPOSITIONS FOR CARE FOR THE ORAL EMPLOYMENT CONTAINING PHYTIC ACID
RU2011152898A (en) CHLORINATED ALKALINE DETERGENT METHANIC ACID PIPELINE
PL2643339T3 (en) Novel hydrotropic agent, use thereof to make non-ionic surfactants soluble, and compositions containing same
BR112012028524A2 (en) pharmaceutical compositions, their uses and methods of preparation, water soluble solid composition and kits
MX2009007265A (en) Salts, aqueous liquid compositions containing salts of s-(+)-abscisic acid and methods of their preparation.
EA201171466A1 (en) COMPOSITION OF UNTESERTAINABLE SALT, METHOD OF ITS RECEPTION AND USE
WO2010136478A3 (en) Method for improving the mildness of cleansing compositions